z-logo
Premium
Antibacterial activity of traditional spices against lower respiratory tract pathogens: combinatorial effects of Trachyspermum ammi essential oil with conventional antibiotics
Author(s) -
Grădinaru A.C.,
Trifan A.,
Şpac A.,
Brebu M.,
Miron A.,
Aprotosoaie A.C.
Publication year - 2018
Publication title -
letters in applied microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.698
H-Index - 110
eISSN - 1472-765X
pISSN - 0266-8254
DOI - 10.1111/lam.13069
Subject(s) - thymol , microbiology and biotechnology , essential oil , ciprofloxacin , antibiotics , staphylococcus aureus , streptococcus pneumoniae , minimum inhibitory concentration , antibacterial activity , biology , bacteria , chemistry , food science , genetics
The aim of this study was to investigate the effects of ajowan essential oil (AjEO)/thymol and antibiotics combinations against three standard strains and six resistant clinical isolates of major respiratory bacteria ( Pseudomonas aeruginosa, Staphylococcus aureus and Streptococcus pneumoniae ). The broth microdilution method was conducted to determine the minimum inhibitory concentrations ( MIC ) of essential oil/thymol and antibiotics. The checkerboard method was used to investigate the interactions between the essential oil/thymol and antibiotics by means of the fractional inhibitory concentration index ( FICI ). The chemical composition of essential oil was also analysed by GC – MS and GC ‐ FID . Thymol (50·75%), γ ‐terpinene (25·94%) and p ‐cymene (18·31%) were identified as major constituents of the oil. The most sensitive organisms to ajowan volatile oil were Strep. pneumoniae bacteria ( MIC  = 0·125–0·5 mg ml −1 ). Synergistic effects were observed with AjEO/thymol and amoxicillin combinations on methicillin‐resistant Staph. aureus clinical isolates ( FICI  = 0·37–0·50) and with essential oil and ciprofloxacin combinations against P. aeruginosa ATCC 27853 , Staph. aureus ATCC 25923 and penicillin (P)‐resistant Strep. pneumoniae bacteria ( FICI  = 0·37–0·50). Combination of thymol and ciprofloxacin produces synergistic effects only against P. aeruginosa ATCC 27853 and P‐resistant Strep. pneumoniae clinical isolate ( FICI  = 0·46–0·49).

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom